Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: June 2016

eXp World Holdings, Inc. (EXPI) Real Estate Buyer/Seller Cloud Environment Offers Refreshing Alternative to Process Complexities

Agent-owned cloud brokerage firm eXp World Holdings, Inc. (OTCQB: EXPI) builds shareholder value by leveraging the use of cloud technology in one of the most entrenched industries of our age. The company’s business model understands that buyers and sellers of … Continue reading

Posted in eXp World Holdings, Inc. EXPI | Leave a comment

Moxian, Inc. (MOXC) Using Gamification to Boost Business Results

Moxian, Inc. (OTCQB: MOXC) is a multi-national company that is committed to building a comprehensive solution using promotional platforms and social marketing to help businesses grow through social media. MOXC’s products enable other merchants to target their marketing, advertising campaigns, … Continue reading

Posted in Moxian Inc. MOXC | Leave a comment

Cellectar Biosciences, Inc. (CLRB) Starts Presentation at Marcum MicroCap Conference

Cellectar Biosciences (NASDAQ: CLRB) is developing phospholipid drug conjugates (PDCs) designed to provide cancer-targeted delivery of diverse oncologic payloads to a broad range of cancers and cancer stem cells. The company’s lead therapeutic PDC, CLR 131, utilizes iodine-131, a cytotoxic … Continue reading

Posted in Marcum MicroCap | Leave a comment

EyeGate Pharmaceuticals, Inc. (EYEG) Starts Presentation at Marcum MicroCap Conference

EyeGate Pharma (NASDAQ: EYEG) is a late-stage specialty pharmaceutical company focused on developing and commercializing therapeutics and drug delivery mechanisms for treating diseases of the eye. The company’s technology addresses two of the most prevalent issues in ophthalmic care: the … Continue reading

Posted in Marcum MicroCap | Leave a comment

TapImmune, Inc. (TPIV) Starts Presentation at Marcum MicroCap Conference

TapImmune (OTCQB: TPIV) is an immunotherapy company specializing in the development of innovative technologies for the treatment of cancer and infectious diseases. The company’s peptide or nucleic acid-based immunotherapeutics comprise one or more naturally processed epitopes designed to comprehensively stimulate … Continue reading

Posted in Marcum MicroCap | Leave a comment

Dataram Corp. (DRAM) Starts Presentation at Marcum MicroCap Conference

Dataram (NASDAQ: DRAM) is an independent manufacturer of memory products and provider of performance solutions that increase the performance and extend the useful life of servers, workstation, desktops and laptops sold by leading manufacturers. Dataram’s memory products and solutions are … Continue reading

Posted in Marcum MicroCap, Small Cap News | Leave a comment

International Stem Cell Corp. (ISCO) Advancing Clinical Development Program for Parkinson’s Disease

International Stem Cell Corp. (OTCQB: ISCO) is a biotechnology company that works with parthenogenesis to treat diseases of the eyes, the nervous system, the liver, and more. Currently, ISCO is preparing for a phase I clinical trial of its proprietary … Continue reading

Posted in International Stem Cell Corp. ISCO | Leave a comment

Car Charging Group, Inc. (CCGI) Starts Presentation at Marcum MicroCap Conference

Car Charging Group (OTC: CCGI) is a pioneer in nationwide public electric vehicle (EV) charging services that enable EV drivers to easily recharge at locations throughout the United States. Headquartered in Miami Beach, Florida, Car Charging Group also has offices … Continue reading

Posted in Marcum MicroCap | Leave a comment

PAVmed, Inc. (PAVMU) Starts Presentation at Marcum MicroCap Conference

PAVmed (NASDAQ: PAVMU) is a multi-product medical device company developing and commercializing a diversified pipeline of innovative products which address unmet clinical needs. The company’s goal is to enhance and accelerate value creation by employing a business model focused on … Continue reading

Posted in Marcum MicroCap | Leave a comment

Spring Bank Pharmaceuticals, Inc. (SBPH) Starts Presentation at Marcum MicroCap Conference

Spring Bank Pharmaceuticals (NASDAQ: SBPH) is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform. The company is developing its most … Continue reading

Posted in Marcum MicroCap | Leave a comment